Research Library
Metabolic Research• Beginner
Is retatrutide FDA approved?
Answer
No. As of July 2026, retatrutide has not been approved by the FDA or any other regulatory agency and remains an investigational compound in clinical trials.
Detailed Explanation
Phase 3 results or company announcements do not constitute regulatory approval. Eli Lilly identifies retatrutide as investigational and states that it is not available for public use; human access is limited to Lilly-sponsored clinical trials. Approval status should be verified through FDA records and current official trial or sponsor information. PepMarket products are strictly for laboratory research and are not for human or veterinary use.